$3 Billion in Shame for Glaxo Smith Kline today, But even more Blame should go to the FDA


Glaxo  is the most recent drug maker to face hefty penalties for improper drug marketing activities.  As reported today,   Glaxo (GSK) agreed to plead guilty and pay $3 billion to resolve allegations that it illegally promoted prescription medicines and failed to report safety data.  The settlement is the largest-ever awarded in a health-care fraud […]